Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study (Q42625324)
Jump to navigation
Jump to search
scientific article published on April 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study |
scientific article published on April 2004 |
Statements
1 reference
Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study (English)
1 reference
Allison Martin
1 reference
Don E Smith
1 reference
Andrew Carr
1 reference
Clare Ringland
1 reference
Sean Emery
1 reference
Jennifer Hoy
1 reference
Cassy Workman
1 reference
Nicholas Doong
1 reference
Judith Freund
1 reference
David A Cooper
1 reference
Mitochondrial Toxicity Study Group
1 reference
1 April 2004
1 reference
Identifiers
1 reference